Sutro Biopharma, Inc. Common Stock (NASDAQ: STRO) last traded at $21.04, down 0.57% on the session. The quote above updates while this page is open; the figures below are drawn from Sutro Biopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Sutro Biopharma, Inc. Common Stock trades on NASDAQ under the ticker STRO. Its market capitalisation is $348.87 million.
Valuation measures for Sutro Biopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $348.87M |
|---|---|
| Enterprise value | $592.31M |
| Price / sales | 7.63 |
| Beta | 1.19 |
Trailing-twelve-month figures tagged in Sutro Biopharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $45.70M |
|---|---|
| Net income (TTM) | -$180.64M |
| Operating margin | -319.57% |
| Cash | $54.34M |
Range and volume for STRO over the past 52 weeks.
| 52-week high | $43.85 |
|---|---|
| 52-week low | $7.15 |
| Volume | 193.6K |
| Average volume | 358.5K |
| Previous close | $21.16 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.